344
Курс лекций по паллиативной медицине
56. Ruiz-Garcia V, Juan O, Perez Hoyos S, et al. [Megestrol acetate:
a systematic review usefulness about the weight gain in neoplastic
patients with cachexia]. MedClin (Barc) 2002; 119:166.
57. Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of
anorexia-cachexia syndrome. Cochrane Database Syst Rev 2005;
CD004310.
58. Ruiz Garcia V, Lopez-Briz E, CarbonellSanchis R, et al. Megestrol
acetate for treatment of anorexia-cachexia syndrome. Cochrane
Database Syst Rev 2013; 3:CD004310.
59. Dev R, Del Fabbro E, Bruera E. Association between megestrol
acetate treatment and symptomatic adrenal insufficiency with
hypogonadisminmale patients with cancer. Cancer 2007; 110:1173.
60. Loprinzi CL, Michalak JC, Schaid DJ, et al. Phase III evaluation
of four doses of megestrol acetate as therapy for patients with cancer
anorexia and/or cachexia. J ClinOncol 1993; 11:762.
61. Miller S, McNutt L, McCann MA, McCorry N. Use of
corticosteroids for anorexia in palliative medicine: a systematic
review. J Palliat Med 2014; 17:482.
62. Loprinzi CL, Kugler JW, Sloan JA, et al. Randomized comparison of
megestrol acetate versus dexamethasone versus fluoxymesterone for the
treatment of cancer anorexia/cachexia. J ClinOncol 1999; 17:3299.
63. Beal JE, Olson R, Laubenstein L, et al. Dronabinol as a treatment
for anorexia associated with weight loss in patients with AIDS. J
PainSymptomManage 1995; 10:89.
64. Beal JE, Olson R, Lefkowitz L, et al. Long-term efficacy and
safety of dronabinol for acquired immunodeficiency syndrome-
associated anorexia. J PainSymptomManage 1997; 14:7.
65. Jatoi A, Windschitl HE, Loprinzi CL, et al. Dronabinol versus
megestrol acetate versus combination therapy for cancer-associated
anorexia: a North Central Cancer Treatment Group study. J
ClinOncol 2002; 20:567.
66. Yeh SS, DeGuzman B, Kramer T, M012 Study Group. Reversal
of COPD-associated weight loss using the anabolic agent
oxandrolone. Chest 2002; 122:421.
67. BhasinS, StorerTW, JavanbakhtM, et al. Testosterone replacement
and resistance exercise in HIV-infected men with weight loss and
low testosterone levels. JAMA 2000; 283:763.
68. Bhasin S, Storer TW, Asbel-Sethi N, et al. Effects of testosterone
replacement with a nongenital, transdermal system, Androderm, in
